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Abstract
Adenosine (Ado) and adenine ribonucleotides are essential in cell metabolism and energy 
production, cellular signaling, and DNA and RNA synthesis. The biosynthesis of these 
molecules takes place in both the intracellular and extracellular space via transphosphorylation 
reactions catalyzed by several distinct kinase enzymes like adenylate kinase. Several analytical 
detection methodologies have been developed to monitor these molecules in biological tissue, 
including both liquid chromatography (LC) and capillary electrophoresis (CE) techniques. 
However, many of these methodologies are limited by separation resolution and sample 
injection volume requirements. This thesis presents a novel capillary electrophoresis-laser 
induced fluorescence detection (CE-LIF) method with high separation power to analyze Ado and 
Inosine (Ino), a metabolite of Ado, by derivatization with 2,4,6-trinitrobenzenesulfonic acid to 
form fluorescent trinitrophenylated complexes of Ado (TNP-Ado) and Ino (TNP-Ino). The 
development and validation of the CE-LIF method, optimization of the trinitrophenylation 
reaction, and fluorescence enhancement of TNP-Ado and TNP-Ino with Y-cyclodextrin will be 
discussed. Detection limits were 1.6 pM for Ado and 4 pM for Ino in rat brain tissue. Large- 
volume sample stacking (LVSS) was employed to further enhance the sensitivity of the CE-LIF 
method, with detections limits of 310 nM and 159 nm for Ado and Ino, respectively. The CE-LIF 
method offers promise for the analysis of Ado, Ino and potentially other adenine ribonucleotides 
in small volume generating biological experiments like in  vivo microdialysis and single cell 
metabolomics.
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Chapter 1
Introduction
1.1 Biological Significance of Adenosine and Adenine Ribonucleotides
Adenosine and adenine ribonucleotides such as adenosine triphosphate (ATP) play a 
number of key roles biological and pathological processes. These roles include cellular 
metabolism,12 cellular signaling,34 and DNA and RNA synthesis.56 Figure 1.1 shows the 
molecular structures of adenosine (Ado) and several essential adenine ribonucleotides. Both 
adenosine and adenine ribonucleotides are comprised of a single, adenine nitrogenous base 
and a 5-carbon ribose sugar ring joined by a p-N9-glycosidic bond between the N9 of the 
adenine base and 1’ carbon of the ribose sugar. Adenine riboucleotides, however, contain 
additional phosphate groups attached to the 5’ carbon of the ribose sugar.
o h  o h
Adenine  Base n h 2 Adenosine 5’-monophosphate (AMP)s
o h  o h
R ibose Sugar 
Adenosine (Ado)
Adenosine 5’-diphosphate (ADP)
o h  o h
Adenosine 5’-triphosphate (ATP)
Figure 1.1. Structures of adenosine and adenine ribonucleotides
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The de novo biosynthesis or metabolic pathways of these molecules takes place in both the 
intracellular and extracellular space. For example, the primary generation of ATP in aerobic 
organisms is through cellular respiration, which occurs intracellularly in the cytosol during 
glycolysis and pyruvate oxidation, and in the mitochondria during the citric acid cycle and 
oxidative phosphorylation.1 Additionally, ATP, other adenine ribonucleotides including 
adenosine 5’ phosphate (ADP) and adenosine 5’ monophosphate (AMP), and Ado can be 
synthesized intracellularly via transphosphorylation reactions.1,7 Figure 1.2 shows the primary 
intracellular pathways for the formation of these molecules. The start of this pathway is typically 
described by the conversion of ATP to ADP by nucleoside-diphosphate kinases (NDPKs) and 
ATPases. After ADP is formed, it can be further converted to 5’-AMP by adenylate kinase and 
eventually to Ado via cytosolic 5’-nucleotidase. As apparent in Figure 1.2, these 
transphosphorylation reactions are reversible and alternative intracellular pathways exist.
Figure 1.2. Primary intracellular de novo biosynthesis pathway fo r the formation of 
adenosine and adenine ribonucleotides. Abbreviations: adenosine 5’-triphosphate (ATP), 
adenosine 5’-diphosphate (ADP), adenosine 5’- monophosphate (AMP), cyclic 5’-adenosine 
monophosphate (cAMP), adenosine (Ado), S-Adenosyl-L-homocysteine (SAH) and nucleoside- 
diphosphate kinases (NDPKs). Figure adapted from Dunwiddie and Masino. 2001.7
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It is also possible that ADP, AMP and Ado can be metabolized extracellularly during certain 
cell signaling events.8-10 Figure 1.3 shows the release of ATP into the extracellular space in a 
cell such as a neuron or epithelial cell. Once ATP is released, it can be metabolized 
extracellularly to its adenine ribonucleotide precursors by ectoenzymes ecto-ATPase and ecto- 
5’ nucleotidases (5’-ectoNT).8 These metabolites can then be further utilized in extracellular 
signaling or transported back into the cell via nucleoside transporters.
Figure 1.3. Extracellular release of ATP and de novo biosynthesis pathway fo r the 
formation of adenosine and adenine ribonucleotides. Abbreviations: adenosine 5- 
triphosphate (ATP), adenosine 5’-diphosphate (ADP), adenosine 5’- monophosphate (AMP), 
adenosine (Ado), equilibrative or concentrative nucleoside transporters (ENT, CNT).
Nucleotide transporters, more specifically equilibrative and concentrative nucleoside 
transporters (ENT, CNT) are essential in maintaining extracellular adenosine concentrations. 
These transporters also play a role in the salvage or recycling of nucleotides when de novo 
biosynthesis of nucleotides is unfavorable.11 ENTs and CNTs are membrane-associated
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proteins that facilitate the bi-directional movement of nucleosides across the cell membrane. 
ENTs transport purine nucleosides like Ado as well as pyrimidine nucleosides across the cell 
membrane depending on the nucleotide concentration gradient.12 CNTs are also bi-directional, 
but the direction of transport is dependent on the cell’s transmembrane sodium gradient 
regardless of the nucleoside concentration gradient.13 In the case of Ado, ENTs and CNTs 
regulate both extracellular end intracellular concentration levels.8 If intracellular Ado levels are 
low due to the normal conversion of Ado to AMP or other metabolites like inosine (Ino), an 
extracellular concentration gradient will form resulting in the influx of Ado through the 
transporters. If there is a diminishment in extracellular Ado concentrations, typically caused by a 
mutation or inhibition of enzymes like adenosine deaminase or adenosine kinase, an 
intracellular Ado accumulation occurs. This reversal of the concentration gradient causes the 
transporters to also reverse direction resulting in a net efflux of Ado into the extracellular space.
The significance of the enzyme adenosine kinase in maintaining extracellular Ado 
concentrations should also be noted. As shown in Figure 1.2, adenosine kinase is responsible 
for the intracellular phosphorylation of Ado to AMP. Adenosine kinase is considered the primary 
regulator of intracellular Ado levels. However more recently, it has also been shown to regulate 
extracellular synaptic Ado concentrations in the CNS, especially in astrocytes, during non- 
pathological conditions.14 This finding is significant because it identifies an additional 
mechanism to nucleoside transporters for maintaining extracellular Ado concentrations.
As stated earlier, Ado and adenine ribonucleotides are essential cellular signaling 
molecules. This type of extraceullar signaling is also referred to purinergic signaling815 and is 
widely distributed across biological tissue.71617 There are two distinct families of purinergic 
receptors, P1 and P2 . P1 receptors, also called adenosine receptors since they are activated 
endogenously by extracellular Ado,18 are G-protein-coupled receptors that signal by inhibiting or 
activating the production of intercellular cyclic AMP. There are 4 subtypes of P1 receptors, A 1, 
A2A, A2B, and A3 . P2 receptors primarily bind ATP, ADP or uracil ribonucleotides and are divided
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in to 2 subtypes, P2X and P2Y.8 1 9  P2X receptors are G-protein-coupled receptors that also signal 
by inhibiting or activating production of intercellular cyclic AMP, where as P2Y receptors are 
ligand-gated channels.
The physiological role of Ado and adenine ribonucleotides, especially in cellular signaling, is 
great. However, the effect and impact of their actions can also vary depending on cell and tissue 
type. In the nervous system, the role of Ado and ATP in normal physiology includes promoting 
and maintaining sleep,20 regulation of glia-neuron communication,21 and the regulation of 
cerebral blood flow.2223 In the cardiovascular system, Ado and ATP help regulate vascular 
tone24 and platelet aggregation,25 as well as cell migration, proliferation and death in endothelial 
and skeletal muscle cells.26 Ado and adenine ribonucleotides also play significant roles in 
maintaining the normal physiology of many other biological processes, including the immune 
response and inflammation,17 bone development and remodeling,27 and insulin secretion in 
pancreatic p-cells.28
In addition, recent research has highlighted the potential of Ado, adenine ribonucleotides, 
and purinergic receptors as key targets for therapeutic interventions in a variety of pathological 
conditions.1629 For example, Ado released during cerebral hypoxia and ischemia exhibits acute 
neuroprotective effects that reduces the severity of damage to local neuronal tissue.30 
Subsequently, Ado agonists and allosteric modulators of P1 receptors have been investigated 
as potential therapies for stroke events.3132
1.2 Current Methodologies to Detect Adenosine and Adenine Ribonucleotides
The widespread role of Ado and adenine ribonucleotides in biological function highlights the 
importance of having analytical methodologies capable of accurately detecting and quantifying 
these molecules in biological tissue. Several of the current methodologies used to monitor these 
molecules, along with their limitations, will be discussed.
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To date, the most commonly used methodology for monitoring Ado and adenine 
ribonucleotides is liquid chromatography (LC). LC separates molecules from complex liquid 
mixtures by passing a solvent, or mobile phase, through a column, or stationary phase, packed 
with an absorbent, stationary material, or stationary phase.33 Column length, solvent and 
analyte polarity as well as analyte size affects the separation resolution and efficiency of LC.33 
For the analysis of Ado and adenine ribonucleotides, LC is typically coupled to UV-Vis 
absorbance detection.3435 However, recent studies have established efficient LC methods 
coupled to mass spectrometry,36-38 fluorescence,39 and electrochemical40 detection. Aside from 
its commonality and convenience, if LC instrumentation is available for use, some limitations 
with the methodology do exist. If large sample injection volumes are required for quantification, 
temporal and spatial sensitivity problems can arise. In addition, large amounts of solvent waste 
can be generated by LC methodologies and can lead to high user costs if high priced solvents 
are required for separation. Despite these pitfalls, recent advancements in LC methodologies 
have been developed to enhance method sensitivity and increase run time efficiency.
One example is a robust liquid chromatography/atmospheric pressure chemical ionization- 
tandem mass spectrometry (LC/APCI-MS/MS) approach developed by Van Dycke et al. for the 
quantification of Ado in cell culture medium.37 Samples were analyzed without the need for 
extraction on a reverse phase LC column. An injection volume of 5 pL was used with a total run 
time of 4.5 min. Quantification of Ado was carried out by MS/MS with a broad concentration 
range from 15.6 ng/ml to 2000 ng/ml. Another robust and sensitive approach using liquid 
chromatography coupled to mass spectrometry (LC-MS) was developed by Song et al. for the 
quantification of Ado (and other neurochemicals) during in vivo brain studies.38 This method 
relies on the derivatization reaction between benzoyl chloride and the ribose-hydroxy group of 
Ado (or primary and secondary amines and phenols groups of other neurochemicals like amino 
acids and dopamine). 5 pL samples of in vivo brain microdialysis were reacted with 2.5 pL of 
benzoyl chloride in 2.5 pL of borate buffer prior to analysis on a reverse phase C18 LC column.
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An injection volume of 9 pL was used with a total run time of 8 min. Quantification of Ado was 
carried out by MS with a reported limit of detection of 25 nM for Ado.
Another methodology used for monitoring Ado and adenine ribonucleotides in biological 
matrices is capillary electrophoresis (CE). Samples are separated electrokinetically by passing 
an applied voltage across a background electrolyte.41 The separation efficiency can be 
manipulated by a variety of variables including the pH of the background electrolyte and the 
additions of background electrolyte modifiers such as cyclodextrin molecules.41 Several CE 
methods have been reported for the analysis of Ado and adenine ribonucleotides, including 
detection by UV-Vis absorbance detection,42 laser induced fluorescence,43 mass spectrometry,44 
and electrochemical45 detection. CE typically has higher separation efficiency than LC and 
requires microliter or less sample injection volumes. A disadvantage of CE can arise if samples 
need to be derivatized or reacted prior to analysis. This not only causes an extra step in 
analysis, but also may lead to sample degradation, matrix interference and an increase in cost.
A recent method that demonstrates the robust separation power of CE is a CE-mass 
spectrometry (CE-MS) approach developed by Liu and colleagues for analysis of nucleotides in 
a single cell.44 The method is able to successfully separate and quantify 16 anionic nucleotides 
(including AMP, ADP and ATP) from a single neuron using a custom-built CE-electrospray 
ionization (CE-ESI) system coupled to a micro-time-of-flight mass spectrometer. Large-volume 
sample stacking was used to concentrate samples during analysis and typically resulted in 103 
nL injection volumes and 40 min run times. Reported limits of detection were 2.2 nM for AMP, 
8.9 nM for ADP, and 6.9 nM for ATP.
Bioluminescence methodologies have also reported for the detect adenine ribonucelotides, 
specifically ATP, in cells.46 The luciferase-luciferin bioluminescence assay relies on requirement 
of ATP for the oxidation of the protein luciferin to oxyluciferin by the firefly enzyme luciferase.47 
The reaction emits light, which can be then detected by spectroscopy techniques. This
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methodology can allow for ATP to be detected in vivo by optic microscopy, however, great care 
has to be made to reduce biomass or other ATP contamination.
Recently, research has focused on developing methodologies that can monitor Ado and 
adenine ribonucleotides in real-time. These methods rely on fast-scan cyclic voltammetry 
(FSCV) probes48 and enzyme-based biosensor technology,49 which can both monitor Ado and 
ATP on a sub-second time scale. Analysis occurs by placing a carbon electrode or nanoparticle 
aptamer-based biosensor into living cells or tissue and rapidly changing its voltage. This causes 
the molecule of interest to either undergo oxidization and reduction rapidly in FSCV or to 
hybridize with the sensor in enzyme-based biosensor technology, thus allowing for appropriate 
detection. Although both of these systems are robust, limitations can arise from signal 
interference by other biological compounds with similar oxidation potential and/or from 
temperature fluctuations since both methods are temperature dependent.
1.3 Summary of Research Aims
It is apparent that almost all current Ado and adenine ribonucleotides detection methods 
have some type of limitation. The primary aim of this thesis was to develop a novel Ado 
detection methodology using capillary electrophoresis-laser induced fluorescence detection 
(CE-LIF) to provide researchers with an alternative, and in some instances a more robust, 
approach for the quantification of Ado in biological samples. This research was based on 
previous work done by Green et al.50 showing the ability of Ado to undergo a trinitrophenylation 
reaction with 2,4,6-trinitrobenzenesulfonic acid (TNBS) to form a stable trinitophenylated 
derivative that exhibits enhanced fluorescence emission when in the presence of Y-cyclodextrin 
(Y-CD). The trinitrophenylated derivative of Ado (TNP-ADO), unlike Ado or adenine 
ribonucleotides alone, has two absorbance maxima of ~410 nm and ~476 nm and a detectable 
single fluorescence emission between 530-560 nm. From this previous work, it was 
hypothesized that TNP-Ado would be detectable by CE-LIF and thus, leading to a novel and
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sensitive method that is capable of monitoring Ado in minute concentrations and sample 
volumes. This research is discussed in Chapter 2 and shows the development, optimization and 
biological application of the CE-LIF method for the analysis of Ado and Inosine, a metabolite of 
Ado.
A secondary aim of this thesis was to expand the CE-LIF method shown in Chapter 2 for the 
analysis of adenine ribonucleotides and structurally similar analogs in biological samples. 
Unfortunately, several complications arose with the CE-LIF analysis of these molecules so more 
research is needed to fully expand the CE-LIF for accurate analysis. Results from this aim will 
be discussed in Appendix B.
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Chapter 2
Analysis o f Trinitrophenylated Adenosine and Inosine using Capillary Electrophoresis- 
Laser Induced Fluorescence Detection and Y-Cyclodextrin1
2.1 Abstract
Monitoring molecules such as adenosine (Ado) and inosine (Ino) in the central nervous 
system has enabled the field of neuroscience to correlate molecular concentration dynamics to 
neurological function, behavior and disease. In vivo sampling techniques are commonly used to 
monitor these dynamics, however, many techniques are limited by the sensitivity and sample 
volume requirements of currently available detection methods. Here, we present a novel 
capillary electrophoresis-laser induced fluorescence detection (CE-LIF) method that analyzes 
Ado and Ino by derivatization with 2,4,6-trinitrobenzenesulfonic acid to form fluorescent 
trinitrophenylated complexes of Ado (TNP-Ado) and Ino (TNP-Ino). These complexes exhibit 
~25 fold fluorescence enhancement upon the formation of inclusion complexes with y- 
cyclodextrin (y-CD). Association constants were determined as 4600 M-1 for Ado and 1000 M-1 
for Ino by CE-LIF and the structure of the TNP-Ado: y-CD association complex was determined 
by 2D nuclear magnetic resonance (NMR) spectroscopy. Optimal trinitrophenylation reaction 
conditions and CE-LIF parameters were determined and resulted in the limit of detection to be
1.6 pM for Ado and 4 pM for Ino. Ado and Ino were simultaneously quantified in homogenized 
rat forebrain samples to illustrate application of the technique. Large-volume sample stacking 
(LVSS) was studied on a dilute TNP-Ado and TNP-Ino solution in water and resulted in a ~10- 
fold enhancement in the method sensitivity.
1 Terilyn K.L. Stephen, Katherine L. Guillemette, and Thomas K. Green. Submitted to Analytical 
Chemistry
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2.2 Introduction
The ability to monitor endogenous and biologically active molecules in the central nervous 
system (CNS) has provided neuroscientists a significant tool in understanding the mechanisms 
behind neurological function, behavior and disease. Much effort has been made in developing 
highly sensitive and fast detection systems that can be used during in vivo and in vitro 
experiments to correlate neurotransmitters and neuromodulators (e.g. glutamate, serotonin and 
dopamine) concentrations to brain function.1-3 More importantly, the recognition for a new 
generation of smaller, low volume sampling probes has also increased the demand for novel 
detection methods that are capable of analyzing molecules in high sensitivity and spatial 
resolution.4-6
One important signaling molecule that has contributed to this demand is adenosine (Ado, 
Figure 2.1A). Ado is a purine ribonucleoside that has both excitatory and inhibitory function in 
neurotransmission7-9 through the activation of 4 receptor subtypes (A1, A2A, A2B and A3). It is 
reported that activation of Ado receptors in the CNS exhibits neuroprotective properties during 
ischemic,1011 hypoxic,1213 and epileptic induced injry.14,15 Ado is also vital in energy 
homeostasis1617 and thermoregulation1819 since it is a precursor for adenosine 5'- 
monophosphate (AMP), 3'-5'-cyclic adenosine monophosphate (cAMP) and adenosine 5’- 
triphosphate (ATP).
Common means to monitoring Ado dynamics in the brain is by in vivo sampling2,20,21 and 
tissue extraction.22,23 Separation and detection of Ado is typically accomplished with liquid 
chromatography (LC) and UV-absorbance2425 but fluorescence,26 mass spectrometry,227 and 
electrochemical23 detection have also been reported. One disadvantage of the LC methods are 
the requirement of microliter sample volumes that can seriously limit temporal resolution during 
in vivo experiments.220 More recently, studies have focused on developing enzymatic1328 and 
fast scan cyclic voltammetry22,29 probes in hopes of eliminating temporal resolution problems by 
measuring Ado on a sub-second time scale during in vivo experiments. Unfortunately,
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compounds with similar oxidation potentials such as hydrogen peroxide and ATP can create 
signal interference and add additional resolution issues.29
Another separation technique with high separation efficiency and a low sample volume 
requirement is capillary electrophoresis (CE). CE has high mass sensitivity and separations are 
not dependent on column length, like LC. Analytes are electrokinetically separated from 
complex matrixes by passing an applied voltage though a background electrolyte (BGE) and 
several detection techniques can be coupled to CE including UV-absorbance,30 laser-induced 
fluorescence,31 and mass spectrometry.32 Online or in-capillary sample preconcentration 
techniques can also be used with CE to enhance the sensitivity and resolution. These 
techniques rely on reducing the band width of the analyte while in the capillary and injection of 
large amounts of the analyte/sample.33 Large-volume sample stacking (LVSS), field-amplified 
sample stacking (FASS) and pH-medicated sample stacking are just several of the reported 
stacking techniques used to improve the limitations of CE.3435
CE coupled with laser-induced fluorescence detection31 (CE-LIF) and fast scan cyclic 
voltammetry (CE-FSCV)22 has also been recently used to monitor Ado in brain tissue 
extractions. However, both methodologies have limitations. The CE-LIF method developed by 
Tseng et al.31 requires Ado to be reacted with chloroacetaldehyde under extreme temperatures 
(95-100oC) to exhibit fluorescence properties. The high heat required for this method can be 
disadvantageous if samples are temperature sensitive and may result in sample degradation 
and/or increased signal interference. The CE-FSCV method by Fang et al.22 uses 
instrumentation that was built in-house, consequently minimizing the accessibility of the method 
to other research groups. Despite these previous efforts, the warrant for a highly sensitive and 
accessible method capable of monitoring Ado in small sample volumes is still unmet, therefore, 
delaying the ability of neuroscientists to further investigate the role of Ado in biological function.
Here, we report a novel CE-LIF method for monitoring Ado (Figure 2.1A) that uses a less 
invasive fluorescence labeling procedure, commercially available instrumentation and the
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potential to use sample-stacking techniques to improve analyte sensitivity when needed. The 
method requires small sample volumes (5 pL) and provides biologically relevant sensitivity as 
well as the ability to quantify inosine (Ino, Figure 2.1A), another biologically significant 
nucleoside. A key step in developing the method was to find a fluorescence labeling procedure 
that was able to react with Ado and be detectable by a CE-LIF system. Earlier studies36-38 had 
shown that Ado could be reacted with 2,4,6-trinitrobenzenesulfonic acid (TNBS) to form a stable 
trinitophenylated derivative (TNP-Ado, Figure 2.1B) that has two absorbance maxima at ~410 
nm and ~476 nm and single fluorescence emission between 530-560 nm. We previously 
investigated the reaction kinetics and steady-state fluorescence of TNP-Ado and discovered 
that the steady state fluorescence of TNP-Ado was enhanced ~100-fold by the addition of y- 
cyclodextrin (y-CD)39. Cyclodextrins (CDs) contain a hydrophobic cavity that can enhance the 
fluorescence emission of smaller molecules by forming inclusion complexes.40 This 
phenomenon was easily translated to the CE-LIF method by the addition of CDs to the BGE. 
We also determined the structure of the TNP-Ado: y-CD using 2D nuclear magnetic resonance 
(NMR) spectroscopy. The trinitrophenylation reaction of Ado and Ino with TNBS was successful 
at submicromolar concentrations in small volumes and resulted in a separation time under 6 
minutes using commercial available CE-LIF instrumentation. Therefore, other research groups 
monitoring these molecules during small volume generating experiments can easily adapt our 
method.
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Figure 2.1. (A) Chemical structures of Adenosine (Ado) and Inosine (Ino). (B) 
Trinitrophenylation reaction scheme between 2,4,6-trinitrobenzenesulfanic acid (TNBS) 
and the ribose group of Ado or Ino to form the TNP complex.
2.3 Methods
2.3.1 Safety Considerations
2,4,6-trinitrobenzenesulfonic acid (TNBS, picrylsulfonic acid, ~1M in H2O) should be handled 
with gloves and precaution. It should not be allowed to dry out, as it is potentially explosive 
when dry. A minor byproduct of the trinitrophenylation reaction between adenosine (Ado) or 
inosine (Ino) and TNBS is picric acid. Picric acid is also potentially explosive when dry.
2.3.2 Chemicals and Reagents
All chemicals were analytical grade and purchased from VWR (Randor, PA) unless 
otherwise noted. Water was purified from a Thermo Scientific GenPure ultrapure water system 
with an 18.2 MQ»cm resistivity. Ino, TNBS, fluorescein and 2-hydroxypropyl-Y-cyclodextrin were
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purchased from Sigma Aldrich (St. Louis, MO). Randomly methylated-Y-cyclodextrin and 
randomly carboxymethylated-Y-cyclodextrin were purchased from CTD, Inc. (Alachua, FL). A 
fresh standard of artificial cerebral spinal fluild (aCSF) solution was prepared as needed and 
contained 120 mM NaCl, 45.7 mM NaHCO3 , 3.3 mM KCl, 1.2 mM NaH2 PO4 , 240 mM MgSO4 , 
50 mM CaCl2 , and 100 mM glucose. For the 0.1 M sodium carbonate buffer at pH 10, equal 
volumes of a 0.2 M sodium bicarbonate and 0.2 M sodium carbonate solution were mixed. The 
background electrolyte (BGE) was 20 mM sodium borate with 2 mM Y-cyclodextrin at pH 9.4 
unless otherwise noted. The BGE was filtered through a 0.2 pm PTFE syringe filter (VWR, 
Randor, PA) prior to use.
2.3.3 Preparation of TNP-Ado and TNP-Ino Standards
A similar procedure to Green et al.39 and Hiratsuka et al.38 was followed. For the TNP 
standards, 60 mg of either Ado or Ino was dissolved in 2 mL of Milli-Q H2O and 0.88 mL of 
TNBS (~1M in H2O) was added. The pH was continuously monitored for 3 hours, adding 1 M 
NaOH until the pH was stabilized at 10. The reaction was left overnight and purified the next 
morning on a Sephadex LH-20 column (Sigma Aldrich, St. Louis, MO). The purified standard 
was retained at the top of the column after eluting impurities with water and appeared as a 
bright reddish-orange band. The standard was eluted from the column with methanol, dried by 
rotary evaporation and analyzed by 1H NMR spectroscopy in D2O to confirm purity (Figure A2.1 
and A2.2 in Appendix A).
2.3.4 1H, HMQC and ROESY NMR Spectra
All NMR spectra were obtained at 600 MHz (Bruker Ascend). Temperature-dependent 1H 
NMR spectra were referenced to D2O according to its known variation of chemical shift with 
temperature. Two-dimensional heteronuclear multiple quantum coherence (HMQC) and 
rotational nuclear Overhauser effect spectroscopy (ROESY) spectra were recorded on 1:1
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mixtures of TNP-Ado and cyclodextrin ( -5  mM each). HMQC spectra were acquired using the
standard pulse sequence provided by Bruker. The standard ROESY pulse sequence and the 
method of phase cycling described by States et al.41 was used. The spectra were collected into 
1024 data points in each block with quadrature detection by using a spectral width of 3000 Hz 
and mixing time of 200 ms. Typically 256 t1 experiments were collected with 32 scans signal 
averaged for each t1 value. The recycle time was 1.5 s. The data were zero-filled in both 
dimensions to give 2048 x 2048 real data points. Gaussian apodization was imposed in each 
dimension prior to Fourier transformation.
2.3.5 CE-LIF Analysis and LVSS Studies
An Agilent Technologies 7100 automated CE system (Santa Clara, CA) coupled to a 
Picometrics Zetalif laser-induced fluorescence detector (France) was used for analysis. A 405 
nm Oxiuxx Laser Diode (France) with the power adjusted to 25 mW was used for an excitation 
wavelength and separations were performed, unless otherwise stated, on a 75 pm ID, 360 pm 
OD fused silica capillary (Polymicro Technologies, Phoenix, AZ). Capillary were cut to a total 
length of 48 cm and an effective length of 20 cm (28 cm to the detection window). New 
capillaries were conditioned for a total of 45 min: 15 min 1 M NaOH, 15 min Milli-Q H2O and 15 
min BGE. All non-sample-stacking separation experiments were performed at 25oC with normal 
polarity at +10 kV (anode at inlet) and hydrodynamic injections were typically 50 mbar for 1 s. 
For LVSS studies, samples were injected hydrodynamically at 50 mbar ranging from 60 to 240 
s. Voltage was applied in reversed polarity at -10 kV (cathode at inlet) until the electric current 
reached 70-95% of the value when filled with BGE. Once reached, the voltage was switched to 
normal polarity at +10 kV and separations proceeded normally. Before each individual run, the 
capillary was preconditioned for 2 min with 0.1 M NaOH followed by 2 min with BGE and post­
conditioned for 2 min with Milli-Q H2O.
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2.3.6 Trinitrophenylation Reactions
Stock solutions, 1 mM of Ado and Ino, were diluted to 0.1 mM in aCSF. Reactions were 
performed in triplicates and 20 pL of 0.1 mM of the standard solution in aCSF was reacted with 
10 pL of TNBS (~1 M in H2O), 10 pL of 1 M NaOH and 120 uL of 0.1 M carbonate buffer at pH 
10. The reactions were vortexed and then placed in a heat block set at either 37 oC or 50oC. To 
determine the percentage of product conversion by CE-LIF analysis, 10 pL of the reaction 
mixture was diluted by 10x in Milli-Q H2O containing 0.02 pM of sodium fluorescein (internal 
standard, IS) and monitored every 2 hours for 10 hr, then at 20 and 24 hrs. Calibration curves 
were made using standards of 8, 40, 80, 400 and 800 pM TNP-Ado and TNP-Ino containing the 
same ratios volumes of TNBS, NaOH and carbonate buffer as the trinitrophenylation reactions 
(1 pL sample to 0.5 pL ~1M TNBS, 0.5 pL 1M NaOH and 6 pL 0.1M carbonate buffer). These 
calibration standards were diluted by 10x prior to CE-LIF analysis in Milli-Q H2O containing 0.02 
pM of internal standard.
2.3.7 Biological Sample Preparation
Tissue samples were prepared from donated adult Sprague-Dawley rat whole brain tissue 
and procedures were followed from previous literature.30 Brain tissue was kept frozen at -80oC 
and forebrain tissue ranging from 50 to 100 mg was removed for analysis. 5 pL of Milli-Q water 
(95-100oC) was added for every 1 mg of tissue and samples were boiled at 95-100oC for 5 min. 
Tissue was homogenized using a VWR disposable pellet mixer (Randor, PA) and centrifuged at 
13000 rmps at 4 oC for 5 mins. Tissue supernatant was then transferred to a 0.22 pm nylon 
centrifuge tube filter (Spin-X, Corning, Inc., Corning, NY), centrifuged at 1300 rmps at 4 oC for 5 
mins, and frozen at -80oC until reacted for analysis. For the reaction, 2.5 pL of TNBS (~1M in 
H2O), 2.5 pL of 1M NaOH and 30 uL of 0.1 M carbonate buffer (pH 10) was added to 5 pL of 
tissue supernatant. Samples were vortexed, placed in a heat block at 50 oC for 6 hr and diluted 
by 10x prior to CE-LIF analysis in Milli-Q H2O containing 0.02 pM of internal standard.
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2.3.8 Statistical Analysis
Analyte peaks were manually integrated using ChemStation software (Agilent Technologies, 
Santa Clara, CA). All values reported are the mean ± standard deviation. Calibration curves 
were constructed using the peak area of the analyte divided by the peak area of the internal 
standard ratio versus concentration of the analyte. For the association (binding) constant 
determination, data was fitted by 2-parameter nonlinear curve fitting42 in GraphPad Prism (La 
Jolla, CA).
2.4 Results and Discussion
2.4.1 CE-LIF Optimization
The CE-LIF parameters were optimized for detection of TNP-Ado and TNP-Ino in 
biologically relevant sample concentrations and volumes using pure TNP standards synthesized 
as previously stated in the methods section. A background electrolyte (BGE) of 20 mM sodium 
borate at pH 9.4 was chosen for the separation of TNP-Ado and TNP-Ino. A basic BGE is 
needed because TNP complexes can ring open at low pH therefore resulting in a loss of stability 
and fluorescence.4344 The integrated fluorescence intensities of TNP-Ado and TNP-Ino were 
significantly enhanced upon the addition of y-CD in the BGE (Figure 2.2 and 2.3). Other 
modified cyclodextrins were investigated for fluorescence enhancement, including 2- 
hydroxypropyl-Y-cyclodextrin, randomly methylated-Y-cyclodextrin, and randomly 
carboxymethylated-Y-cyclodextrin, but none provided enhancement above that of y-CD, and all 
were more expensive. The addition of 2 mM y-CD in the BGE (Figure 2.2A) showed 
approximately a 30-fold and 17-fold fluorescence enhancement for TNP-Ado (10 pM) and TNP- 
Ino (10 pM), respectively. These results are in general agreement with the Green et al.39 study 
that reported an ~100-fold enhancement in the integrated steady-state fluorescence intensity of 
TNP-Ado (4 pM) with 10 mM y-CD compared to water alone. The addition of 2 mM y-CD in the
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BGE delivered stable baselines and reproducible separations and its addition was further 
confirmed by calculation of association constants, later discussed.
Time (min)
Figure 2.2. Effect o f y-CD concentration on the separation and fluorescence of TNP-Ado 
(10 pM), TNP-Ino (10 pM), TNBS (~12.5 mM) and fluorescein (internal standard, IS, 0.02 
pM) dissolved in aCSF and 0.1 M carbonate buffer at pH 10. (A) 2 mM y-CD; (B) 0.2 mM y-
CD, (C) 0 mM y-CD. Peak identification: 1 TNP-Ado, 2 TNP-Ino, 3 TNBS, 4 IS. CE Parameters: 
Inner capillary diameter 75 pm; total length 40 cm; effective length 28 cm; injection pressure 50 
mbar; injection time 1 s; applied voltage 10 kV; laser power 25 mW; 25oC; BGE 20 mM sodium 
borate with various y-CD concentrations at pH 9.4.
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[y-CD] (mM)
Figure 2.3. Effect of y-CD on the integrated fluorescence of a 10 standard of TNP-Ado 
in water. CE-LIF parameters: Inner capillary diameter 50 pm; effective length 28 cm; injection 
pressure 50 mbar; injection time 1 s; applied voltage 20 kV; laser power 25 mW; BGE 20 mM 
sodium borate with various y-CD concentrations at pH 9.4.
2.4.2 Determination of y-CD Association Constants
The ability of y-CD to enhance the fluorescence and shorten the migration time of the TNP- 
complexes is based on the CDs ability to form inclusion complexes with small molecules.40 
Because CDs contain a hydrophobic cavity, small molecules with nonpolar regions can 
associate with the cavity in equilibrium. As shown in Figure 2.2, an increase in y-CD 
concentration alters the migration (mobility) time of TNP-Ado and TNP-Ino. This relationship can 
be used to characterize the association or binding interactions between the y-CD and the TNP- 
complexes.
Green et al.39 determined that TNP-Ado forms a 1:1 complex with y-CD. Assuming 1:1 
stoichiometry, the equilibrium between y-CD, the TNP-Complex and inclusion complex can be 
modeled by a simple reversible complexation (Equation 1 and 2).
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y-CD + TNP-Complex w  yCD-TNP-Complex (1)
K  _  [Y-CD-TNP-Complex] (2)
[Y-CD][TNP-Complex] ( )
The association (binding) constant, K, measures the affinity of the TNP-Complex to bind with 
Y-CD and can be experimentally determined by CE methods.45 In CE, the separation of analytes 
in a complex mixture is dependent on the actual electrophoretic mobility of the analyte (pep) and 
the electroosmostic flow (EOF) mobility (peof), the pumping mechanism resulting from the 
movement of charges through the capillary when current is applied.46 The strength and direction 
of the pep and peof are largely dependent on the pH and concentration of the BGE46 and as a 
result, the observed electrophoretic mobility of an analyte (pobs) is the sum of the pep and peof 
vectors (Equation 3).
pobs= pep ± peof (3)
The association constant, K, can be expressed as a function of CD concentration and the 
actual electrophoretic mobilities of the free, unbound analyte (pf) and the bound inclusion 
complex (uc). Rundlett and Armstrong4245 derived an equation that can be experimentally solved 
for K by 2 parameter nonlinear curve fitting (Equation 4)
p _  pf + pcK[CD] (4)
Mi 1+K[CD] v '
where pi is the experimentally measured electrophoretic mobility of the inclusion complex, y- 
CD-TNP-complex, pf is the electrophoretic mobility of the free, unbound TNP-Complex, pc is an
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estimation of the electrophoretic mobility of the bound inclusion complex at the maximum CD 
concentration and CD is the concentration of y-CD.
The actual electrophoretic mobilities (pi) of a 10 pM standard of TNP-Ado and TNP-Ino were 
plotted as a function of y-CD concentration (Figure 2.4). The concentration of y-CD that was 
added to the BGE ranged from 0 to 0.010 M (10mM). It is expected that the addition of y-CD to 
the BGE would change the BGE viscosity and thus, alter the mobility of the inclusion 
complexes. However the measured change in BGE viscosity upon the addition of y-CD was 
negligible. These results allowed us to calculate the electrophoretic mobilities (pi) without 
correcting for a change in BGE viscosity. Based on Figure 2.4, it was also determined that the 
addition of 2 mM y-CD to the BGE provided a maximum decrease in the electrophoretic 
mobilities (pi) of TNP-Ado and TNP-Ino.
[y-CD] (M)
Figure 2.4. The relationship between the electrophoretic mobility ^i (cm2/V»s) of 10 
standards of TNP-Ado and TNP-Ino and concentration of y-CD (M) at 25 oC. See Figure 23  
for CE-LIF parameters.
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As also shown in Figure 2.4, plots were fitted with Equation 44245 by 2-parameter non-linear 
curve fitting, K and pc as variables. The association constants for TNP-Ado and TNP-Ino were 
calculated to be 4600 ± 460 M-1 with a R2 of 0.9779 and 1000 ± 190 M-1 with a R2 of 0.9348, 
respectively (Table 2.1). Based on the similarities in chemical structure, it was predicted that the 
association constants of TNP-Ado and TNP-Ino would yield similar values. This prediction was 
based on the assumption that the trinitrophenyl group of the complex associates with y-CD, not 
the nucleotide base. 39 Our results, however, show that TNP-Ino has a lower affinity for y-CD 
compared to TNP-Ado. The lower association constant can be explained by the fact that TNP- 
Ino possesses an acidic amido hydrogen located on the nucleotide base with a pKa of 8.8.47 
Since the pH of the BGE is 9.4, the dianionic form of TNP-Ino predominates in solution and 
results in an increase in water solubility. We suggest that this increase in solubility causes the 
TNP-Ino molecule to reduce its affinity for forming an inclusion complex with y-CD and thus, 
results in a lower association constant compared to TNP-Ado.
2.4.3 Structural Determination of TNP-Ado and y -CD Inclusion Complex
To further investigate the strong association between TNP-Ado with y-CD, we used 2D NMR 
to determine the structure of the TNP-Ado: y-CD inclusion complex. Green et al.39 have 
conducted NMR studies on the TNP-Ado: y-CD inclusion complex using ROESY experiments. 
However, a definitive interpretation of their results was not provided.
Hydrogen assignments for both TNP-Ado and y-CD were determined using the Green et 
al.39 study and further confirmed using HMQC experiments on ~5 mM solutions of y-CD (no 
TNP-Ado) and a 1:1 mixture of TNP-Ado: y-CD in D2O (see Figure A2.3 and A2.4 in Appendix 
A). In the presence of y-CD, the aromatic H-2 and H-8 of the adenine base of TNP-Ado appear 
as singlets at ~8.25 and ~8.15 ppm, respectively (see top of spectra in Figure 2.5 and structure 
in Figure 2.6). The two Htnp resonances of the TNP moiety are assigned to 7.90 and 8.43 ppm 
and are anisochronous hydrogens (Figure 2.5 and 2.6). The broadening of all 4 hydrogen
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resonances in the presence of y-CD is indicative of the strong association between TNP-Ado 
with y-CD.39
Ea
ppm
Figure 2.5. Partial 2D ROESY spectrum o f 1:1 mixture of y-CD and TNP-Ado (~5mM each) 
in D2O. Mixing time 200ms.
In order to understand the resonance assignments and the structural interaction between 
TNP-Ado and y-CD, the structure of y-CD should be noted. The H-3 and H-5 of the D-glucose 
units of y-CD are directed internally towards the hydrophobic cavity, where as H-2 and H-4 are 
directed externally.3948 The two H-6 hydrogens are positioned on the primary rim of the CD, 
which are and are nonequivalent and diastereotopic.3948 The H-3 and H-5 resonances of y-CD 
are assigned to the triplet at 3.8 ppm and a multiplet at 3.74 ppm, respectively (Figure A2.3 in 
Appendix A). The H-2, H-4 and 2 H-6 designated as H-6 and H-6’ resonances are assigned to 
3.52, 3.46 and 3.74 ppm, respectively (Figure A2.3 in Appendix A). The 1H NMR spectra of y-CD
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in the absence and presence of TNP-Ado are shown on the side in Figure 2.5. This illustrates 
the upfield shift of H-6’ resonance on the primary rim of y-CD when in the presence of TNP-Ado. 
This is indicative of a strong association with TNP-Ado and may be a result of ring current 
effects of the TNP moiety but further investigated is needed to support this hypothesis.
To provide a more definitive interruption of the TNP-Ado: y-CD inclusion complex structure, 
2D ROESY NMR was acquired for a 1:1 TNP-Ado: y-CD mixture in D2O (Figure 2.5). Intense 
through-space correlations are seen with H-2 and H-8 hydrogens on the adenine base and the 
downfield region (3.7-3.85 ppm) of the y-CD. This region contains the internally directed H-3 
and H-5 resonances and a single H-6 resonance of y-CD. Because H-2 and H-8 of TNP-Ado 
show no correlations to the upfield region (3.45-3.55 ppm) containing the external H-2, H-4 and 
H-6’ resonances of y-CD, it can be concluded that adenine base of the TNP-Ado molecule is 
only interacting with the H-3 and H-5 hydrogens of y-CD. Strong through-space correlations 
between the two Ht n p  resonances of the TNP-Ado molecule and both the upfield and downfield 
regions of y-CD are also seen in Figure 2.5. Due to the correlation with both regions, it can be 
presumed that the Ht n p  resonances are interacting with the primary H-6 hydrogens of y-CD.
Figure 2.6 illustrates the proposed structural determination of the TNP-Ado: y-CD inclusion 
complex. These results conflict with the findings presented in the Green et al.39 study. Green 
originally hypothesized that the TNP moiety of the TNP-Ado complex inserts itself in the 
hydrophobic cavity containing H-3 and H-5 of y-CD. This was primarily based on a good size- 
shape match of y-CD and TNP-Ado since their NMR studies could not provide a definitive 
structure. Our results, however, provide strong evidence that the adenine base of the TNP-Ado 
molecule inserts itself into the primary rim of y-CD. This model also accounts for the reduced 
affinity of the dianionic TNP-Ino molecule forming an inclusion complex with y-CD since the 
nucleotide base is inserting in the cavity of y-CD.
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[ OH ]16
Figure 2.6. Proposed inclusion complex of TNP-Ado: y-CD.
2.4.4 Trinitrophenylation Reaction Kinetics Monitored by CE-LIF
In order to ensure the trinitrophenylation of Ado and Ino would be successful at biologically 
relevant concentrations and in small volumes, the reaction kinetics were monitored by CE-LIF. 
The reaction kinetics of Ado and Ino were monitored with the goal of 90-100% analyte 
conversion to its corresponding TNP-Complex in a reasonable timeframe and by using a 
reaction procedure that could be easily translated to the detection of Ado and Ino in various 
biological matrices (e.g. tissue, plasma, brain microdialysate).
Trinitrophenylation reactions were optimized for time, temperature, reagent concentrations 
and solvent conditions. The trinitrophenylation of Ado and other nucleic acids have been studied 
in large volumes (2-5 mL) and at millimolar concentration by UV-Vis absorption.363744 The rate 
of Ado conversion is also highly dependent on the pH and composition of the buffer system 
used.3744 Azegami and Iwai37 reported that a 0.5 M sodium carbonate buffer system at pH 10.0 
resulted in a 50% reaction time of 21 min for the conversion of Ado (10 mM) to TNP-Ado at
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37oC. The trinitrophenylation of Ado (100 pM) in 3 concentrations of sodium carbonate buffers at 
pH 10 (0.1 M, 0.15 M and 0.5 M) was monitored at 37oC for 20 hr (See Figure A2.5 in Appendix 
A). Interestingly, the 100 pM Ado reaction in a 0.5 M sodium carbonate buffer at pH 10 resulted 
in a lower Ado conversion rate compared to the 0.1 M and 0.15 M sodium carbonate reactions. 
The maximum percent conversion was less than 60% after 20 hr at all sodium carbonate 
concentrations.
Because of the low conversion rates of Ado at 37oC, the trinitrophenylation reaction was 
monitored at a reaction temperature of 50oC. We predicted that at a higher temperature, the 
reaction rates of Ado and Ino with TNBS would increase and thus, result in a conversion rate 
close to 100% while yielding a shorter reaction time. A 100 pM standard of Ado and Ino in aCSF 
was then reacted with TNBS (0.06 M) in a 0.1 M sodium carbonate buffer at pH 10 at 50oC and 
analyte conversion rates were monitored over 24 hr.
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Figure 2.7. Rates of the trinitrophenylation of Ado (100 ^M) at 50oC and 37oC and Ino (100 
^M) at 50oC. Reaction monitored as the % conversion of Ado and Ino to the trinitrophenlaytion 
products of TNP-Ado and TNP-Ino, respectively. See Figure 2 for CE-LIF parameters not stated; 
BGE 2 mM y-CD in 20 mM sodium borate at pH 9.4.
Figure 2.7 shows a comparison of the percent conversion of Ado and Ino to its 
corresponding TNP-Complex as a function of reaction time and temperature (37oC and 50oC). 
The trinitrophenylation of Ado at 50oC resulted in ~100% (101 ± 6) conversion to TNP-Ado after 
6 hr where as at 37oC, the maximum Ado conversion was ~60% (59 ± 3) after 24 hours. There 
were no signs of TNP-Ado degradation at 50oC since the Ado conversion rate was stable at 
100% after 24 hr. The conversion of Ino to TNP-Ino at 50oC was lower at ~67% (67 ± 2) but also 
showed no degradation of the TNP-Ino complex after formation. These reactions were also 
conducted using 20 pL sample volumes and optimized reagent quantities. It was determined 
that for every 1 pL of sample: 0.5 pL of TNBS (~1M in H2O), 0.5 pL of 1M NaOH and 6 pL of 
0.1M carbonate buffer at pH 10 were needed to have successful trinitrophenylation of Ado
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(~100% conversion after 6 hr) and Ino (~67 % after 6 hr). The addition of 1 M NaOH is required 
to ensure the pH of the reaction mixture is sustained above 9.5 since reactions performed at 
neutral and acidic pH values show a lower TNP-complex yield.4344 These results confirmed that 
the trinitrophenylation of Ado and Ino is possible at a biological relevant concentration and 
volumes and, after formation, the TNP-complexes are stable for analysis by the CE-LIF method.
2.4.5 CE-LIF Method Validation
The repeatability, sensitivity and linear response of the CE-LIF method were tested (Table 
2.1). The repeatability of both the analytical method and the trinitrophenylation reaction was 
determined by the average relative standard deviation (RSD) of 3 individual trinitrophenylated 
reactions of an 80 pM Ado and Ino solution in aCSF. 5 pL volumes of the Ado/Ino solutions 
were reacted with 2.5 pL of 1 M TNBS, 2.5 pL of 1 M NaOH, 30 pL of 0.1 M carbonate buffer at 
50°C. The limit of detection (LOD) and limit of quantification (LOQ) were calculated from the 
same samples based on a signal to noise (S/N) ratio of 3 for LOD and of 10 for LOQ. The LOD 
and LOQ values reported in Table 2.1 are corrected for the 80x dilution factor required for 
analysis, 8x due to the trinitrophenylation reaction and 10x in H2O for CE-LIF analysis.
Table 2.1. Values fo r CE-LIF Methoda
Associat ion % Forebrain
Analyte ' i S E S ?  % RSDC LODC LOQC y=mx+bd R2 C ^
ir /n /in  after 6 hr at (n=3) (S/N=3) (S/N=10) 3 Concentration
K (M ) 50oCc (n=3)
Ado 4600 ± 460 101 ± 6 9.0 1.6 i^M 5.3 i^M y=2.012x-0.8304 0.9980
Ino 1000 ± 190 67 ± 2 5.4 4 ^M 13.3 ^M y=2.225x -0.9561 0.9923
14.2 ± 1.7 
nmol/mg
6.4± 0.8 
nmol/mg
aTable represents analytical validity of the CE-LIF method for Ado and Ino detection. Association  
constants were calculated by 2-parameter nonlinear curve fitting for a 10 pM trinitrophenyled Ado (TNP- 
Ado) and Ino (TNP-Ino) standard over a range of y-Cyclodextrin (y-CD) concentrations (0-10mM). c% 
conversion, % RSDs, % conversion, LOD and LOQ were calculated by comparing the analyte peak area 
to IS peak area of 3 individual trinitrophenylated standards with a concentration of 80 pM and in 5 pL 
volumes after 6 hours of reaction. dThe method linearity was tested over a pre-reaction range of 8-800 
pM. eRat forebrain tissue concentrations were determined in triplicate from 5 pL of homogenated tissue 
supernatant and after 6 hours of the trinitrophenylation reaction.
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2.4.6 Analysis of Adenosine and Inosine in Rat Brain Tissue
To demonstrate the application of the method, whole tissue homogenates from rat forebrain 
were analyzed. Forebrain tissue samples were removed from frozen whole rat brain samples, 
homogenized and extracted according to previous literature.30 5 ^L samples of extracted tissue 
supernatant were then reacted in triplicate using the optimized reagent ratio of 1 ^L sample 
volume to 0.5 ^L of TNBS (~1M in H2O), 0.5 ^L of 1M NaOH and 6 ^L of 0.1M carbonate buffer 
at pH 10. Samples were kept at 50oC for 6 hr and then diluted 10x in H2O prior to analysis.
Figure 2.8 shows the electropherograms of the trinitrophenylated forebrain tissue sample 
and a 5 ^L standard of 8 ^M Ado and Ino reacted under the same conditions after 6 hr. Ado and 
Ino concentrations in the forebrain are reported in Table 2.1 and are within the range of previous 
reports of Ado analyzed in brain tissue by enzymatic49 and HPLC24 methods. It should be noted 
that Ado concentrations cannot be directly compared to previous studies because there are 
apparent differences in Ado concentrations due to variations in animal sacrifice methods, brain 
regions analyzed, and tissue homogenization procedures. Nonetheless, the results shown in 
Figure 2.8 validate the capability of the method to detect and quantify Ado and Ino in biological 
samples with a high separation efficiency. The success of the trinitrophenylation reaction in 5 ^L 
of biological sample establishes a reaction procedure that could be used during in vivo studies 
like microdialysis, which generate small volumes and require good temporal and spatial 
resolution. Overall, the CE-LIF method provides a sensitive and novel technique for the analysis 
of Ado and Ino in brain tissue.
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Figure 2.8. Electropherograms of a 5 pL sample o f rat forebrain homogenate (A) and an 
80 pM Ado and Ino standard (B) after 6 hours o f reaction time. Peak identification: 1 TNP- 
Ado, 2 TNP-Ino, 3 TNBS, 4 IS. See Figure 2 for CE-LIF parameters not stated; BGE 2 mM y-CD 
in 20 mM sodium borate at pH 9.4.
2.4.7 Large-Volume Sample Stacking of TNP-Ado and TNP-Ino
Trinitrophenylation of the Ado and Ino required an 8x dilution. The derivatized sample is then 
further diluted with water prior to CE analysis to enhance peak shape, resulting in an overall 
dilution of 80x. The LODs and LOQs reported in Table 2.1 take into account this dilution, and are 
thus in the micromolar range. In an effort to lower the detection limits, LVSS was employed for 
both TNP-Ado and TNP-Ino.
In Figure 2.9, a 20 nM standard of TNP-Ado and TNP-Ino in water was stacked by 50 mbar 
hydrodynamic injections ranging from 5 to 240 s. Reverse polarity (negative voltage) was 
applied for each sample run except for the 5 s run until the electric current reached between 85 
to 95% of the normal polarity value when the capillary was filled with BGE. We observed a ~10-
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fold enhancement in the LODs for 60 to 240-s injections of TNP-Ado and TNP-Ino compared to 
the 5-s non-LVSS injection (Table 2.2). With LVSS, the estimated LOD without accounting for 
the 80x dilution factor is ~4 nM for TNP-Ado and ~2.5 nM for TNP-Ino. Figure 2.10 shows an 
electropherogram of 180-s injection for a 4 nM standard of TNP-Ino and TNP-Ino in water. The 
ability to successfully detect TNP-Ado and TNP-Ino at the LOD concentration of 4 nM (320 nM 
accounting for the 80x dilution factor) concentration highlights the promise in our method to 
detect nanomolar or lower sample concentrations.
Figure 2.9. Large-volume sample stacking (LVSS) of TNP-Ado (20 nM) and TNP-Ino (20 
nM) standards in water. Arrows indicate time of polarity switch. Peak identification: 1 TNP-Ado, 
2 TNP-Ino. See Figure 2 for CE-LIF parameters not stated; injection pressure 50 mbar; injection 
time 5-240 s; BGE 2 mM y-CD in 20 mM sodium borate at pH 9.4.
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Table 2.2. LVSS Values for a 20 nM standard of TNP-Ado and TNP-Ino in H2O.
Injection 
time (s)a
%
Capillary
Filled
Polarity
Switch
(min)
LOD (S/N=3)b
Ado Ino
5 2 - 3.33 mM 1.53 mM
60 28 0.7 310 nM 159 nM
120 56 1.7 431 nM 240 nM
180 83 2.7 472 nM 234 nM
240 111 3.7 369 nM 195 nM
Corresponding electropherograms shown in Figure 9. Non-LVSS sample is represented by 5 s 
injection. bLOD values are corrected for the 80x dilution factor required by CE-LIF method.
Time (min)
Figure 2.10. LVSS electropherogram of a 4 nM standard of TNP-Ino and TNP-Ino in water.
Peak identification: 1 TNP-Ado, 2 TNP-Ino.. See Figure 2 for CE-LIF parameters not stated; 
injection pressure 50 mbar; injection time 180 s; 2 mM y-CD in 20 mM sodium borate BGE at 
pH 9.4.
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2.5 Conclusions
The ability of the CE-LIF method to utilize the fluorescence enhancement properties of y-CD 
to measure TNP-Ado and TNP-Ino with submicromolar sensitivity and in small sample volumes 
has been demonstrated. The method allows for a robust detection system that uses a less 
invasive fluorescence labeling procedure than previously reported and one that has the ability to 
be used for the analysis of other biologically significant nucleosides. Although future studies are 
needed to optimize the use of sample-stacking techniques to improve analyte sensitivity when 
needed, the high separation resolution and use of commercially available reagents and 
instrumentation makes this method valuable and applicable to other research groups studying 
the role of Ado in biological disease, disorders and therapeutic development.
2.6 Acknowledgments
We thank Dr. Kelly Drew and lab members for tissue samples and discussions, Dr. Carl 
Murphy for NMR discussions, Dr. Canrong Qiu for help with graphics and Dr. Robert Kennedy 
and Dr. Mohamed Dawod for sample stacking advice. Research reported in this publication was 
supported in part by the Alaska Space Grant Program, National Institute of Neurological 
Disorders and Stroke of the National Institutes of Health under grant number R15NS074422, 
and an Institutional Development Award (IDeA) from the National Institute of General Medical 
Sciences of the National Institutes of Health under grant number P20GM103395. The content is 
solely the responsibility of the authors and does not necessarily reflect the official views of the 
NIH.
39
40
2.7 References
(1) Fillenz, M. Neuroscience & Biobehavioral Reviews 2005, 29, 949-962.
(2) Song, P.; Mabrouk, O. S.; Hershey, N. D.; Kennedy, R. T. Analytical chemistry 2011, 84, 
412-419.
(3) Parrot, S.; Sauvinet, V.; Riban, V.; Depaulis, A.; Renaud, B.; Denoroy, L. Journal of 
neuroscience methods 2004, 140, 29-38.
(4) Chen, C.-f.; Drew, K. L. Journal of Chromatography A 2008, 1209, 29-36.
(5) Slaney, T. R.; Nie, J.; Hershey, N. D.; Thwar, P. K.; Linderman, J.; Burns, M. A.; Kennedy, 
R. T. Analytical chemistry 2011, 83, 5207-5213.
(6) Hogerton, A. L.; Bowser, M. T. Analytical chemistry 2013, 85, 9070-9077.
(7) Xia, J.; Xiong, J.; Wang, H.; Duan, S.; Ye, J.; Hu, Z. Neuroscience 2012, 201, 46-56.
(8) Borycz, J.; Pereira, M. F.; Melani, A.; Rodrigues, R. J.; Kofalvi, A.; Panlilio, L.; Pedata, F.; 
Goldberg, S. R.; Cunha, R. A.; Ferre, S. Journal of neurochemistry 2007, 101, 355-363.
(9) Zhang, P.; Bannon, N. M.; Ilin, V.; Volgushev, M.; Chistiakova, M. The Journal of physiology 
2015.
(10) Williams-Karnesky, R. L.; Stenzel-Poore, M. P. Current neuropharmacology 2009, 7, 217.
(11) Horiguchi, T.; Shimizu, K.; Ogino, M.; Yamaguchi, N.; Suga, S.; Inamasu, J.; Kawase, T. 
Brain research 2002, 952, 222-231.
(12) Cui, M.; Bai, X.; Li, T.; Chen, F.; Dong, Q.; Zhao, Y.; Liu, X. PloS one 2013, 8, e57065.
(13) Frenguelli, B.; Llaudet, E.; Dale, N. Journal of neurochemistry 2003, 86, 1506-1515.
(14) Fedele, D. E.; Li, T.; Lan, J. Q.; Fredholm, B. B.; Boison, D. Experimental neurology 2006, 
200, 184-190.
(15) Gouder, N.; Fritschy, J. M.; Boison, D. Epilepsia 2003, 44, 877-885.
(16) Porkka-Heiskanen, T.; Kalinchuk, A. V. Sleep medicine reviews 2011, 15, 123-135.
(17) Koupenova, M.; Ravid, K. Journal of cellular physiology 2013.
(18) Jinka, T. R.; Carlson, Z. A.; Moore, J. T.; Drew, K. L. Psychopharmacology 2010, 209, 217­
224.
(19) Ticho, S. R.; Radulovacki, M. Pharmacology Biochemistry and Behavior 1991, 40, 33-40.
(20) Chen, L.-S.; Fujitaki, J.; Dixon, R. Journal of Liquid Chromatography & Related 
Technologies 1993, 16, 2791-2796.
41
(21) Porkka-Heiskanen, T.; Strecker, R.; McCarley, R. Neuroscience 2000, 99, 507-517.
(22) Fang, H.; Pajski, M. L.; Ross, A. E.; Venton, B. J. Analytical Methods 2013, 5, 2704-2711.
(23) Pani, A. K.; Jiao, Y.; Sample, K. J.; Smeyne, R. J. PloS one 2014, 9, e92422.
(24) Wojcik, W.; Neff, N. Journal of neurochemistry 1982, 39, 280-282.
(25) Coolen, E. J.; Arts, I. C.; Swennen, E. L.; Bast, A.; Stuart, M. A. C.; Dagnelie, P. C. Journal 
of Chromatography B 2008, 864, 43-51.
(26) Haink, G.; Deussen, A. Journal of Chromatography B 2003, 784, 189-193.
(27) Van Dycke, A.; Verstraete, A.; Pil, K.; Raedt, R.; Vonck, K.; Boison, D.; Boon, P. Journal of
chromatography. B, Analytical technologies in the biomedical and life sciences 2010, 878, 1493­
1498.
(28) Dale, N.; Gourine, A. V.; Llaudet, E.; Bulmer, D.; Thomas, T.; Spyer, K. M. The Journal of 
physiology 2002, 544, 149-160.
(29) Ross, A. E.; Venton, B. J. Analytical chemistry 2014.
(30) Ozer, N.; Aksoy, Y.; Ogus, I. H. Journal of biochemical and biophysical methods 2000, 45, 
141-146.
(31) Tseng, H. C.; Dadoo, R.; Zare, R. N. Analytical biochemistry 1994, 222, 55-58.
(32) Phan, N. T.; Hanrieder, J. r.; Berglund, E. C.; Ewing, A. G. Analytical chemistry 2013, 85, 
8448-8454.
(33) Lian, D.-S.; Zhao, S.-J.; Li, J.; Li, B.-L. Analytical and bioanalytical chemistry 2014, 1-22.
(34) Lee, S. Y.; Muller, C. E. Electrophoresis 2014, 35, 855-863.
(35) Kirschner, D. L.; Jaramillo, M.; Green, T. K. Analytical chemistry 2007, 79, 736-743.
(36) Azegami, M.; Iwai, K. Journal of biochemistry 1964, 55, 346-348.
(37) Azegami, M.; Iwai, K. Journal of biochemistry 1975, 78, 409-420.
(38) Hiratsuka, T.; Sakata, I.; Uchida, K. Journal of biochemistry 1973, 74, 649-659.
(39) Green, T. K.; Denoroy, L.; Parrot, S. The Journal of Organic Chemistry 2010, 75, 4048­
4055.
(40) Hoshino, M.; Imamura, M.; Ikehara, K.; Hama, Y. The Journal of Physical Chemistry 1981, 
85, 1820-1823.
(41) States, D.; Haberkorn, R.; Ruben, D. Journal of Magnetic Resonance (1969) 1982, 48, 286­
292.
42
(42) Rundlett, K. L.; Armstrong, D. W. Journal of Chromatography A 1996, 721, 173-186.
(43) Ye, J. Y.; Yamauchi, M.; Yogi, O.; Ishikawa, M. The Journal of Physical Chemistry B 1999, 
103, 2812-2817.
(44) Ah-kow, G.; Terrier, F.; Pouet, M.-J.; Simonnin, M.-P. The Journal of Organic Chemistry 
1980, 45, 4399-4404.
(45) Rundlett, K. L.; Armstrong, D. W. Electrophoresis 2001, 22, 1419-1427.
(46) Weinberger, R. Practical capillary electrophoresis, 2nd ed.; Academic Press: San Diego, 
California, 2000.
(47) Psoda, A.; Shugar, D. Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein 
Synthesis 1971, 247, 507-513.
(48) Schneider, H.-J.; Hacket, F.; Rudiger, V.; Ikeda, H. Chemical reviews 1998, 98, 1755-1786.
(49) Winn, H.; Rubio, R.; Berne, R. American Journal of Physiology-Heart and Circulatory 
Physiology 1981, 241, H235-H242.
43
44
Chapter 3
Conclusion 
3.1 Overview
The primary focus of this thesis was to develop a novel analytical methodology using 2,4,6- 
trinitrobenzenesulfonic acid (TNBS) derivatization and capillary electrophoresis-laser induced 
fluorescence detection (CE-LIF) to detect and quantify adenosine (Ado) in biological systems. 
Our work includes the development of a CE-LIF method, optimization of the trinitrophenylation 
reaction used to create the detectable form of Ado (TNP-Ado), fluorescence enhancement of 
TNP-Ado with Y-cyclodextrin, and biological validation of the CE-LIF method in rat brain tissue. 
We also were able to successfully detect and quantify the molecule inosine, a metabolite of 
Ado, in rat brain tissue using the CE-LIF method. The limits of detection were 1.6 ^M for Ado 
and 4 ^M for Ino. Large-volume sample stacking (LVSS) of Ado and Ino was employed to 
further enhance the sensitivity of the CE-LIF method, with detections limits of 310 nM and 159 
nm for Ado and Ino, respectively.
3.2 Future Directions
The work described in this thesis provides a novel methodology for the analysis of both Ado 
and Ino in biological tissue. The advantages of using a CE-LIF detection method would 
potentially allow researchers to quantify these molecules in small volume and low concentration 
generating experiments like in vivo microdialysis. Future studies should focus on optimizing CE- 
LIF sample stacking techniques like LVSS and field-amplified sample stacking (FASI) in order to 
enhance the sensitivity and robustness of the CE-LIF method. In addition, future research 
should include the expansion of the CE-LIF method to selectively detect and quantify adenine 
ribonucletides like ATP and AMP. Results from this research would potentially provided
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biomedical researchers with the appropriate analytical tool to further understand the role of Ado 
and adenine ribonucleotides in normal physiology, pathological conditions and therapeutic 
intervention.
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Appendix A 
Supporting Information fo r Chapter 2
Figure A2.1. 1H-NMR of synthesized TNP-Adenosine standard in D2O. (Varian 300 MHz).
47
D  VO OO OO
\  r \ j  f \  r j  o  o»
x i  c d  g o  o o  GO N
— ^ L_—
lO  ID
V
in^j-mroo'CTioars
r r r r ^ r r r m c n c n c n c n c n c o c o
J l
8.0 7.5 7.0 6.5 6.0
ppm
5.5 5.0 4.5 4.0 3.5
Figure A2.2. 1H-NMR of synthesized TNP-Inosine standard in D2O. (Bruker 600 MHz).
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Figure A2.4. HMQC of 1:1 mixture of TNP-Ado: y-CD (~5mM each) in D2O. (Bruker 600 
MHz).
50
pp
m
60-i
co
■55
(U>co
o
o■c
<
40-
20-
«  •
▲
•  •
T
5
—r~
10
—r~
15
—r~
20
- i
25
Time (hr)
0
0
Figure A2.5. Effect of 0.1, 0.15 and 0.5 M sodium carbonate buffer at pH 10 on the 
trinitrophenylation of Ado (100 uM) at 37oC. 0.15 M sodium carbonate (blue circles), 0.15 M 
sodium carbonate (green squares) and 0.5 M Sodium Carbonate (purple triangles). CE-LIF CE- 
LIF parameters: Inner capillary diameter 50 ^m; effective length 28 cm; injection pressure 50 
mbar; injection time 1 s; applied voltage 20 kV; laser power 25 mW; 2 mM y-CD in 20 mM 
sodium borate BGE at pH 9.4.
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Appendix B
Trinitrophenylation and Capillary Electrophoresis Analysis of Adenine Ribonucleotides, 
N6-Cyclohexyladenosine, Guanosine, Cytidine, and Uridine
B.1 Additional Analysis on Adenosine 
B.1.1 Introduction
To supplement the research discussed in Chapter 2 of this thesis, additional steady state 
fluorescence spectroscopy and capillary electrophoresis-laser induced fluorescence (CE-LIF) 
experiments were carried out for analysis of adenosine (Ado), see Figure B1.1 for structure. All 
experiments were performed using a trinitrophenylated standard of Ado (TNP-Ado) that was 
synthesized using the procedure discussed in Chapter 2 and reported in Green et al.1.
B.1.2 Methods
For the steady state fluorescence spectroscopy experiments, 10 ^M samples of TNP-Ado 
were prepared in various aqueous and non-aqueous solvents: Milli-Q H2O, 20 mM sodium 
borate with 2 mM Y-cyclodextrin at pH 9.4, analytical-grade methanol, analytical- grade acetone, 
dimethylformamide (DMF) and N, N-dimethylformamide (NMF). Samples were analyzed at
OH OH
Figure B1.1. Structure of Adenosine (Ado).
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ambient temperature and in replicate. A Perkin Elimer LS 50 B luminescence spectrometer with 
a 408 nm excitation wavelength was used.
An Agilent Technologies 7100 automated CE system coupled to a Picometrics Zetalif laser- 
induced fluorescence detector was used for CE-LIF analysis. A 405 nm Oxiuxx Laser Diode with 
the power adjusted to 25 mW was used for an excitation wavelength and separations were 
performed on a 75 ^m ID, 360 ^m OD fused silica capillary. Capillary were cut to a total length 
of 48 cm and an effective length of 20 cm (28 cm to the detection window). New capillaries were 
conditioned for a total of 45 min: 15 min 1 M NaOH, 15 min Milli-Q H2O and 15 min background 
electrolyte. (BGE). The BGE used for analysis was typically 20 mM sodium borate with 2 mM y- 
cyclodextrin at pH 9.4, but other cyclodextrins and cyclodextrin concentrations were tested. 
Other cyclodextrins used were (2-hydroxypropyl)-Y-cyclodextrin (2-HP-y-CD), 3A-amino-3A- 
deoxy-(2AS, 3AS)-Y-cyclodextrin (Amino-Y-CD), randomly methylated-Y-cyclodextrin (Methyl-Y- 
CD) and randomly carboxymethlated-Y-cyclodextrin (Carboxymethylated-Y-CD). BGE was 
filtered through a 0.2 ^m PTFE syringe filter prior to use. All experiments were performed at 
25oC with normal polarity at +10 kV (anode at inlet) and hydrodynamic injections were typically 
50 mbar for 1s.
For the comparison of Ado concentrations in rat brain tissue using different extraction 
techniques, various solvents and methods were used2-4. Brain tissue was kept frozen at -80oC 
and forebrain tissue ranging from 50 to 100 mg was removed from whole brain for analysis. For 
Ado extractions requiring the boiling of tissue samples, 5 ^L of either Milli-Q water (95-100oC), 
20 mM sodium borate with 2 mM Y-cyclodextrin at pH 9.4 (95-100oC) or 0.1 M sodium carbonate 
buffer at pH 10 (95-100oC) was added for every 1 mg of tissue and samples were boiled at 95- 
100oC for 5 min. For extractions using cold techniques, 5 ^L of either 5% Perchloric acid (PCA), 
50 mM Tris(hydroxymethyl)aminomethane (TRIS) containing 2 mM ethylenediaminetetraacetic 
acid (EDTA), 20 mM sodium borate with 2 mM Y-cyclodextrin at pH 9.4 or 0.1 M sodium 
carbonate buffer at pH 10 was added for every 1 mg of tissue. Samples were set on ice and
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incubated for 5 min. After boiling or cold preparation, tissue was homogenized using a 
disposable pellet mixer and centrifuged at 13000 rmps at 4 oC for 5 min. Tissue supernatant was 
then transferred to a 0.22 jm  nylon centrifuge tube filter centrifuged at 1300 rmps at 4 oC for 5 
mins, and frozen at -80oC until reacted for analysis. For the trinitrophenylation reaction, 2.5 jL  
of TNBS (~1M in H2O), 2.5 |jL of 1M NaOH and 30 uL of 0.1 M carbonate buffer (pH 10) was 
added to 5 jL  of tissue supernatant. Samples were vortexed, placed in a heat block at 50 oC for 
6 hr and diluted by 10x prior to CE-LIF analysis in Milli-Q H2O containing 0.02 jM  of internal 
standard.
B.1.3 Results and Discussion
It has been well reported that non-aqueous solvent systems can improve fluorescence 
emission of smaller aromatic molecules in capillary electrophoresis.56 To investigate whether a 
non-aqueous BGE would be more benefitual for the anaylsis of TNP-Ado using CE-LIF, the 
steady state fluoresence emission of TNP-Ado in several common non-aqueous solvents was 
compared. Figure B1.2 shows this comparison for a 10 j M TNP-Ado standard. Overall, acetone 
resulted in a 76-fold fluorescence enhancement of TNP-Ado over water alone and a 1.5-fold 
fluorescence enhancement of TNP-Ado in 20 mM sodium borate with 2 mM Y-cyclodextrin at pH 
9.4. DMF also resulted in a 58-fold fluorescence enhancement of TNP-Ado over water alone, 
but only a 1.1-fold fluorescence enhancement of TNP-Ado in 20 mM sodium borate with 2 mM 
Y-cyclodextrin at pH 9.4. Although acetone and DMF resulted in an increased fluorescence 
emission of TNP-Ado, we determined the additional enhancement of only 1.1-1.5-fold was not 
worth the cost of switching to a non-aqueous CE-LIF system for the analysis of Ado. Other 
factors also impacted this decision including the price of non-aqueous solvents and the 
evaporation risk of working with volatile of solvents.
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Figure B1.2. Steady state fluorescence emission of 10 TNP-Ado standard in various 
aqueous and non-aqueous solvents. Abbreviations: Milli-Q H2O (H2O), 20 mM sodium borate 
with 2 mM Y-cyclodextrin at pH 9.4 (y-CD), dimethylformamide (DMF) and N, N- 
dimethylformamide (NMF).
Another parameter in the CE-LIF method that could be manipulated to increase the 
fluorescence emission of TNP-Ado is the addition of cyclodextrins to the BGE. Green et al. had 
shown an ~110-fold enhancement in the steady state fluorescence emission of a 4 ^M TNP-Ado 
sample in 10 mM of y-CD compared to water alone.1 Using this knowledge, we compared the 
relative fluorescence peak height of a 10 ^M TNP-Ado standard in H2O using CE-LIF with 
several modified y-CD at various concentrations in 20 mM sodium borate BGE at pH 9.4 (Figure 
B1.3). At 0.5 mM CD concentration, both the randomly methylated-Y-CD and the 2-HP-y-CD 
increased the fluorescence emission by at least a factor of 3 for TNP-Ado compared to y-CD in 
the BGE. As shown in Figure B1.3, it takes 10 times the concentration of y-CD to achieve this 
same maximal increase in TNP-Ado fluorescence. This result is promising because it indicates 
that the maximal enhancement in TNP-Ado fluorescence can be achieved using less
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cyclodextrin. However, if the price of cyclodextrin is also considered, ~$170/gram for randomly 
methylated- y-CD vs ~$20 for 2-HP- y-CD vs $10/gram for y-CD, these findings become 
negligible as it would not be cost effective to use a higher priced CD in this system.
y-c d
2-HP-y-CD
Amino-Y-CD
Methyl-Y-CD
Carboxymethyl-Y-CD
[CD] (mM)
Figure B1.3. Comparison of relative fluorescence peak height of 10 TNP-Ado standard 
in H2O using CE-LIF with various types and concentrations of cyclodextrins in 20 mM 
sodium borate BGE at pH 9.4. CE-LIF parameters: Inner capillary diameter 75 ^m; total length 
48 cm, effective length 28 cm; injection pressure 50 mbar; injection time 1 s; applied voltage 20 
kV; laser power 25 mW. Abbreviations: Y-cyclodextrin (Y-CD), 2-hydroxypropyl)-Y-cyclodextrin 
(2-HP-y-CD), 3A-amino-3A-deoxy-(2AS, 3AS)-Y-cyclodextrin (Amino-Y-CD), randomly 
methylated-Y-cyclodextrin (Methyl-Y-CD) and randomly carboxymethlated-Y-cyclodextrin 
(Carboxymethylated-Y-CD)
After all the parameters for the CE-LIF method were optimized as discussed in Chapter 2, 
biological validation was tested using tissue extracts from rat forebrain. Numerous extraction 
techniques are used in the literature instead of a single standard for the analysis of Ado.2-4 This 
could be potentially problematic if reported Ado concentrations are directly compared from 
various sources using different extraction techniques. Chida et al. investigated this potential 
problem for ATP and found that different extraction techniques resulted in major discrepancies 
in final ATP concentrations.7 To briefly investigate this potential dilemma while also searching
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for the most user-friendly extraction technique for Ado, several extraction techniques were 
performed on tissue samples and then analyzed using CE-LIF
Figure B1.4 shows the comparison of Ado concentrations in rat forebrain tissue using 
different sample extraction techniques and solvents. No apparent differences were found 
between boiling tissue samples in either Milli-Q H2O or 0.1 M carbonate buffer and cold 
preparation in 0.1 M carbonate buffer. A 0.1 M carbonate buffer was chosen as a solvent 
because it is essential in the trinitrophenylation reaction step of the CE-LIF method. It is also 
apparent that the use of PCA, Tris and EDTA, and 20 mM Borate with 2 mM y-CD resulted in 
different Ado concentrations compared to the other methods. It should be noted that because 
spike recovery experiments were not performed with these samples, we are unable to directly 
quantify and compare these values.
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Figure B1.4. Comparison of Ado concentrations in rat forebrain tissue using different 
sample extraction techniques. CE-LIF parameters: Inner capillary diameter 75 ^m; total 
length 48 cm, effective length 28 cm; injection pressure 50 mbar; injection time 1 s; applied 
voltage 20 kV; laser power 25 mW. Abbreviations: 5% perchloric acid (PCA), 50 mM 
tris(hydroxymethyl)aminomethane (TRIS) containing 2 mM ethylenediaminetetraacetic acid 
(EDTA), 20 mM sodium borate with 2 mM Y-cyclodextrin pH 9.4 (20 mM Borate + y-CD) at or 
0.1 M sodium carbonate buffer at pH 10 (0.1 M Carbonate).
B.1.4 Conclusions
The additional results presented for Ado broaden the scope and potential of the CE-LIF 
method presented in Chapter 2. Future studies should further investigate the use of non- 
aqueous solvent systems in the analysis of TNP-Ado and related compounds as well as 
determine if the use of other cyclodextrins in the BGE can enhance the selectivity of the CE-LIF 
system. Spike-recovery experiments should also be performed when comparing tissue 
extraction techniques so reported Ado concentrations can be quantifiable and directly compared 
in order to determine the most reliable extraction method.
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B.2 Adenine Ribonucleotides 
B.2.1 Introduction
As stated in Chapter 1, adenine ribonucleotides including adenosine 5’-monophosphate 
(AMP), adenosine 5’-diphosphate (ADP) and adenosine 5’-triphosphate are important in cell 
signaling and metabolism.8,9 The structures of these molecules are shown in Figure B2.1 and 
contain diol functional groups, which can potentially undergo trinitrophenylation with 2,4,6- 
trinitrobenzenesulfonic acid (TNBS) to form a stable trinitrophenylated derivatives (TNP-AMP, 
TNP-ADP and TNP-ATP). Previous studies have successfully synthesized and characterized 
the spectroscopic properties of TNP-ATP.10-12
n h 2 n h 2
o h  o h  o h  o h
Adenosine 5'-m onophosphate (AMP) Adenosine 5'-d iphosphate (ADP)
n h 2
A denosine 5'-triphosphate (ATP)
Figure B2.1. Structures of Adenine Ribonucleotides
In order to broaden the impact of the CE-LIF method described in Chapter 2, a secondary 
aim of this thesis was to expand the CE-LIF method for the analysis of adenine ribonucleotides 
in biological samples. The synthesis of pure TNP-AMP, TNP-ADP and TNP-ATP was attempted 
as well as preliminary CE-LIF analysis of TNP-AMP and TNP-ATP standards in H2O.
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B.2.2 Methods
A method similar to Green et al.1 and Hiratsuka et al.12 was followed for the 
trinitrophenylation of AMP, ADP and ATP. For the TNP-AMP standard, ~60 mg of AMP was 
dissolved in 1 mL of Milli-Q H2O and 1 mL 1M NaOH followed by the addition of 0.88 mL of 
TNBS (~1M in H2O). For TNP-ADP and TNP-ATP, ~60 mg of either ADP or ATP was dissolved 
in 2 mL of Milli-Q H2O and 0.88 mL of TNBS (~1M in H2O was added. The pH of all reactions 
was continuously monitored for 3 hours, adding 1 M NaOH until the pH was stabilized at 10. 
Each reaction was left overnight and purified the next morning on a Sephadex LH-20 column, 
dimensions 2 cm x ~30 cm. Impurities of each reaction were eluded off the column with water, 
leaving the purified standard, which appeared as a bright reddish-orange band, retained at the 
top of the column. The standard was then eluted from the column with methanol, dried by rotary 
evaporation and ~10 mg of the final product was analyzed for purity by 600 MHz NMR 
spectroscopy in D2O.
For the CE-LIF analysis of TNP-AMP and TNP-ATP, the NMR samples of each standard 
was diluted 1:1000 in Milli-Q H2O. After initial analysis, each sample was spiked with 2 ^L TNBS 
(~1M in H2O) an run under the same conditions. Separations were performed on a 75 ^m inner 
diameter fused silica capillary cut to a total length of 48 cm and an effective length of 28 cm. 
The background electrolyte solution consisted of 20 mM sodium borate with 2 mM y- 
cyclodextrin at pH 9.4 and was filtered through a 0.2 ^m syringe filter prior to use. Samples 
were hydrodynamically injected at 50 mbar for 2 seconds and 5 seconds for TNP-AMP and 
TNP-ATP, respectively, and run for a total 13 minutes at 10 kV.
B.2.3 Results and Discussion
The trinitrophenylation of AMP yielded a pure standard. Figure B2.2 shows the 1H NMR of 
TNP-AMP with correct hydrogen assignments. The large unassigned peaks with singlet 
multiplicities at ~4.6 ppm and ~8.8 ppm are D2O and residual TNBS, respectively. A 31P NMR
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spectrum was also collected to further confirm the purity of TNP-AMP (Figure B2.3). A pure 
TNP-AMP standard would result in a single phosphate resonance in the 31P NMR spectrum. 
This is confirmed in Figure B2.3.
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Figure B2.2. 1H NMR of TNP-AMP in D2O (Bruker 600 MHz)
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Figure B2.3. 31P NMR of TNP-AMP in D2O (Bruker 600 MHz)
The next step in expanding the CE-LIF method for the analysis of adenine ribonucleotides 
was to analyze the TNP-AMP standard using the same conditions as for the analysis of TNP- 
Ado. This was also done to determine the potential of the method to separate TNP-AMP from 
TNP-Ado and TNBS. Figure B2.4 shows the electropherogram of a TNP-AMP standard in H2O 
as well as the same sample with a TNBS spike. Unfortunately under these conditions, the CE- 
LIF method could not separate TNP-AMP from TNBS as shown by the doubling of the TNP- 
AMP signal after the addition of TNBS. However, it can be presumed that under this condition 
the CE-LIF method would have the potential to separate TNP-AMP from TNP-ADO since TNP- 
Ado is typically detected at ~ 6 min and TNP-AMP is detected after 7 min.
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Figure B2.4. CE-LIF electropherogram of TNP-AMP and TNP-AMP with TNBS spike. CE
Parameters: Inner capillary diameter 75 pm; total length 40 cm; effective length 28 cm; injection 
pressure 50 mbar; injection time 2 s; applied voltage 10 kV; laser power 25 mW; 25oC; BGE 20 
mM sodium borate with various y-CD concentrations at pH 9.4.
The trinitrophenylation of ADP also yielded a pure standard. Figure B2.5 shows the 1H NMR 
of TNP-ADP with correct hydrogen assignments. The large unassigned peak with multiplicity of 
a singlet at ~4.6 ppm is D2O. A 1H COSY NMR is shown is Figure B2.6 and used to confirm 
hydrogen peak assignment. A 31P NMR spectrum was also collected to further confirm the purity 
of TNP-ADP (Figure B2.7). A pure TNP-ADP standard would result in two doublets, 
corresponding to the two coupled phosphorus nuclei in TNP-ADP. This is confirmed in Figure 
B2.7.
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Figure B2.5. 1H NMR of TNP-ADP in D2O (Bruker 600 MHz)
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Figure B2.6. 1H COSY NMR of TNP-ADP in D2O (Bruker 600 MHz)
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Figure B2.7. 31P NMR of TNP-ADP in D2O (Bruker 600 MHz)
The trinitrophenylation of ATP did not yield a pure standard. Figure B2.8 shows the 1H NMR 
of TNP-ATP with most of the hydrogens correctly assigned. A 1H COSY NMR is shown is Figure 
B2.9 and used for determining correct peak assignments. However, the two hydrogens located 
on the adenine base, which can be typically assigned for other TNP compounds, cannot be 
correctly identified in Figure B2.8. A 31P (Figure B2.10) and 31P COSY NMR (Figure B2.11) was 
also acquired to determine the degree of purity of the TNP-ATP standard. A pure TNP-ATP
standard would result in three resonances with multiplicities of a triplet and two doublets that
correspond to the three phosphates in TNP-ATP. As shown in Figure B2.10, multiple chemical 
shifts appear the TNP-ATP standard. One potential explanation for this result is that TNP-ATP is 
hydrolyzing while in solution into its metabolites TNP-ADP and TNP-AMP.
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Figure B2.8. 1H NMR of TNP-ATP in D2O (Bruker 600 MHz). Hydrogens on the adenine base 
could not be correctly assigned.
N* N
*
O
68
4.0
4.5 
_5.0 
-5.5 
- 6.0 
-6.5 
-7.0 
-7.5 
- 8.0
8.5
ppm
Figure B2.9. 1H COSY NMR of TNP-ATP in D2O (Bruker 600 MHz)
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Figure B2.10. 31P NMR of TNP-ATP in D2O (Bruker 600 MHz)
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Figure B2.11. 31P COSY NMR of TNP-ATP in D2O (Bruker 600 MHz)
Although it was determined that the synthesis of TNP-ATP did not yield a pure standard, 
CE-LIF analysis was performed using the same conditions as for the analysis of TNP-Ado. 
Figure B2.12 shows the electropherogram of the synthesized TNP-ATP standard in H2O as well 
as the same sample with a TNBS spike. As predicted from the NMR, the electropherogram of 
the standard resulted in multiple signals. This result also highlights that the CE-LIF method 
could not separate TNBS from the TNP-ATP signals as shown by the increase in peak height of 
one of the TNP-ATP signals.
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Figure B2.12. CE-LIF electropherogram o f TNP-ATP and TNP-ATP with TNBS spike. CE
Parameters: Inner capillary diameter 75 pm; total length 40 cm; effective length 28 cm; injection 
pressure 50 mbar; injection time 2 s; applied voltage 10 kV; laser power 25 mW; 25oC; BGE 20 
mM sodium borate with various y-CD concentrations at pH 9.4.
B.2.4 Conclusions
Pure standards of TNP-AMP and TNP-ADP were successfully synthesized. Future studies 
should work towards optimizing the purification step of the trinitrophenylation reaction for TNP- 
ATP to minimize impurities and possible hydrolysis. Experiments should be performed with pure 
standards of TNP-Ado, TNP-AMP, TNP-ADP and TNP-ATP in order to determine optimal CE- 
LIF conditions for successful analytical separation and quantification. Once these studies are 
complete, the trinitrophenylation reaction kinetics of each of these molecules at biologically 
relevant concentrations and volumes should be investigated to determine a standard reaction 
procedure. Lastly, once an optimized CE-LIF method and trinitrophenylation reaction procedure 
is developed for TNP-AMP, TNP-ADP and TNP-ATP, the expansion of the CE-LIF method for
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the detection of adenine ribonucleotides can be validated in real biological samples like brain 
tissue or microdialysis samples.
B.3 N6-Cyclohexyladenosine 
B.3.1 Introduction
Due to the significance of Ado and adenine ribonucleotides in cellular signaling, several 
structurally similar analogs have been developed for potential use as pharmaceutical 
interventions in a variety of pathological conditions and disease.13-15 One of these analogs is N6- 
Cyclohexyladenosine (CHA), structure shown in Figure B3.1. CHA is a selective A1 adenosine 
receptor agonist and is of great interest to Dr. Kelly Drew’s research group at UAF because of 
its role in inducing entrance into torpor16 and a hypothermic, torpor-like state17 in hibernators 
and non-hibernators, respectively. Because of this interest, we were asked if the CE-LIF method 
could be also used to analyze CHA in rat brain tissue. Similarly to Ado, which is discussed in 
Chapter 2 of the thesis, a standard of trinitrophenylated CHA (TNP-CHA) was synthesized in 
addition to CE-LIF optimization studies for potential detection of CHA in biological tissue.
OH OH
Figure B3.1. Structure of N6-Cyclohexyladenosine (CHA)
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B.3.2 Methods
A method similar to Green et al.1 and Hiratsuka et al.12 was followed for the 
trinitrophenylation of CHA. ~60 mg of CHA was dissolved in 1 mL of Milli-Q H2O and 1 mL 1M 
NaOH followed by the addition of 0.88 mL of TNBS (~1M in H2O). The pH of the reaction was 
continuously monitored for 3 hours, adding 1 M NaOH until the pH was stabilized at 10. The 
reaction was left overnight and purified the next morning on a Sephadex LH-20 column, 
dimensions 2 cm x ~30 cm. Impurities were eluded off the column with water, leaving the 
purified standard, which appeared as a bright reddish-orange band, retained at the top of the 
column. The standard was then eluted from the column with methanol, dried by rotary 
evaporation and analyzed for purity by 600 MHz NMR spectroscopy in DMSO-d6.
For binding studies using CE-LIF, a 10 ^M sample of the TNP-CHA standard was diluted in 
H2O and the background electrolyte (BGE) solution consisted of 20 mM sodium borate with 
various Y-cyclodextrin concentrations at pH 9.4. The BGE was filtered through a 0.2 ^m syringe 
filter prior to use. Separations were performed on a 50 ^m inner diameter fused silica capillary 
cut to a total length of 48 cm, effective length 28 cm. Samples were hydrodynamically injection 
at 50 mbar for 1 s. Applied voltage was 20 kV and laser power was 25 mW.
A stock solution of CHA was diluted to 0.1 mM in aCSF for monitoring of the 
trinitrophenylation reaction by CE-LIF. Reactions were performed in triplicates and 20 ^L of 0.1 
mM of the standard solution in aCSF was reacted with 10 ^L of TNBS (~1 M in H2O), 10 ^L of 1 
M NaOH and 120 uL of 0.1 M carbonate buffer at pH 10. The reactions were vortexed and then 
placed in a heat block set at 50oC. To determine the percentage of product conversion by CE- 
LIF analysis, 10 ^L of the reaction mixture was diluted by 10x in Milli-Q H2O containing 0.02 ^M 
of sodium fluorescein (internal standard) and monitored every 2 hours for 10 hr, then at 20 and 
24 hr. Calibration curves were made using standards of 8, 40, 80, 400 and 800 ^M TNP-CHA 
containing the same ratios volumes of TNBS, NaOH and carbonate buffer as the 
trinitrophenylation reactions (1 ^L sample to 0.5 ^L ~1M TNBS, 0.5 ^L 1M NaOH and 6 ^L 0.1M
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carbonate buffer). These calibration standards were diluted by 10x prior to CE-LIF analysis in 
Milli-Q H2O containing 0.02 ^M of internal standard. CE-LIF conditions were similar to the 
binding studies, however, a 75 ^m inner diameter fused silica capillary cut to a total length of 48 
cm, effective length 28 cm, was used and applied voltage was set at 10 kV.
For comparing a CHA standard before and after 24 hr storage at -80oF, a 1 mM sample was 
prepared in aCSF. The sample was then analyzed before and after storage by 1H NMR 
spectroscopy using the same parameters like the number of scan etc.
B.3.3 Results and Discussion
The trinitrophenylation of CHA yielded a pure standard. Figure B3.2 shows the 1H NMR of 
TNP-CHA with correct hydrogen assignments. The large unassigned peaks at ~2.5 ppm and 
~3.4 ppm are residual H2O and DMSO, respectively. A 1H COSY NMR is shown is Figure B3.3 
and aided in determining correct peak assignments.
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Figure B3.3. 1H COSY NMR of TNP-CHA in DMSO-d6 (Bruker 600 MHz)
A sample of the TNP-CHA, TNP-Ado, TNBS and the internal standard fluorescein in aCSF 
was analyzed by CE-LIF under the same conditions typically used for Ado detection. Figure 
B3.4 shows the electropherogram of this sample and resulted in the successful separation of 
TNP-CHA from TNP-Ado, TNBS and the internal standard. This result demonstrations the 
potential of the CE-LIF method to analyze not only endogenous molecules, but also structurally 
similar analogs.
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Figure B3.4. CE-LIF electropherogram o f TNP-Ado, TNP-CHA, TNBS and IS in aCSF. CE
Parameters: Inner capillary diameter 75 pm; total length 48 cm; effective length 28 cm; injection 
pressure 50 mbar; injection time 1 s; applied voltage 10 kV; laser power 25 mW; 25oC; BGE 20 
mM sodium borate with various y-CD concentrations at pH 9.4.
In order to quantify the analysis of CHA by CE-LIF, y-CD association constants and 
trinitrophenylation reaction kinetics studies were completed. Figure B3.5 shows the relationship 
between the electrophoretic mobility of TNP-CHA and concentration of y-CD. Similarly to the 
research discussed in Chapter 2, 2-parameter non-linear curve fitting was performed. The 
association constant for TNP-CHA was calculated to be 2700 ± 320 M-1. This result was 
significantly lower than the association constant calculated for TNP-Ado, 4600 ± 460 M-1, 
suggesting that TNP-CHA has a weaker association with y-CD compared to TNP-Ado.
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Figure B3.5. The relationship between the electrophoretic mobility ^  (cm2/V»s) of 10 ^M 
standard of TNP-CHA and concentration of y -CD (M) at 25 oC. CE-LIF parameters: Inner 
capillary diameter 50 ^m; effective length 28 cm; injection pressure 50 mbar; injection time 1 s; 
applied voltage 20 kV; laser power 25 mW; BGE 20 mM sodium borate with various y-CD 
concentrations at pH 9.4.
Figure B3.6 shows a comparison of the percent conversion of CHA to TNP-CHA as a 
function of reaction time and at 50oC. The same reaction conditions were used as the Ado 
trinitrophenylation studies in Chapter 2 (For every 1 ^L of sample: 0.5 ^L of TNBS (~1M in 
H2O), 0.5 ^L of 1M NaOH and 6 ^L of 0.1M carbonate buffer at pH 10 are added). The 
trinitrophenylation of CHA at 50oC resulted in ~100% conversion to TNP-CHA after 2 hr. There 
were no signs of TNP-CHA degradation at 50oC since the CHA conversion rate was stable after 
24 hr.
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Figure B3.6. Rate of the trinitrophenylation of CHA (100 ^M) at 50oC. CE Parameters: Inner 
capillary diameter 75 pm; total length 48 cm; effective length 28 cm; injection pressure 50 mbar; 
injection time 1 s; applied voltage 10 kV; laser power 25 mW; 25oC; BGE 20 mM sodium borate 
with various y-CD concentrations at pH 9.4.
After determining a optimal trinitrophenylation reaction procedure for CHA, the next step in 
expanding the CE-LIF method for the analysis of CHA was to validate the method in biological 
tissue. Several attempts to analyze CHA in homogenized rate brain tissue were made, but 
eventually determined unsuccessful. In order to ensure the reaction procedure was valid, 
standards containing CHA in aCSF were reacted and analyzed simultaneous with tissue 
samples spiked with CHA after the homogenization/extraction processing but prior to storage at 
-80oF and trinitrophenylation. However, it became apparent that the tissue samples spiked with 
CHA resulted in limited or no detection of CHA by CE-LIF where as CHA was detectable in the 
control reactions. This result suggested that CHA could be potentially degrading prior to 
analysis.
To further investigate if CHA was degrading prior to analysis, a preliminary NMR study was 
performed on a solution of CHA in aCSF before and after 24 hr storage at -80oF. The 1H NMR 
spectra of the solution before and after storage are shown in Figure B3.7. The same sample
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and NMR parameters were used for each spectrum acquisition. Only one hydrogen signal was 
used for comparison. These results suggested that after 24 hr storage at -80oF, there is some 
evidence that CHA is starting to degrade. This is determined by comparing the peak heights and 
areas of the two spectra, which are not the same before and after storage at -80oF.
Same 1mM CHA 
after 24 hr at -80oF
8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3
ppm
Figure B3.7. Comparison of 1H NMR of 1mM CHA standard in aCSF diluted in D2O before
and after 24 hr storage at -80oF (Bruker 600 MHz).
B.3.4 Conclusions
A pure standard of TNP-CHA was successfully synthesized and separated from a TNP-Ado 
standard. From the reaction kinetic experiments, a standard procedure was established for the 
trinitrophenylation CHA. More research is needed to determine the cause of CHA degradation
and the inability of the CE-LIF method to successfully detect CHA in biological samples.
Experiments should be designed to minimize storage of tissue homogenate prior of analysis and
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incorporate additional controls to ensure successful trinitrophenylation and analysis of CHA in 
addition to other endogenous molecules like Ado and ATP.
B.4 Guanosine, Cytidine and Uridine 
B.4.1 Introduction
Other ribonucleosides including Guanosine (Gua), Cytidine (Cyt) and Uridine (Uri) exist in 
nature and play a number of key roles cell signaling, RNA synthesis and metabolism.18 Similarly 
to Ado, these molecules contain a 5-carbon ribose sugar ring joined by a p-Ng-glycosidic bond 
to a nitrogenous base. Figure B4.1 shows the molecular structures of Gua, Cyt and Uri. Due to 
the presence of the diol functional groups, there is potential that these molecules can also 
undergo trinitrophenylation with 2,4,6-trinitrobenzenesulfonic acid (TNBS) to form stable 
trinitrophenylated derivatives (TNP-Gua, TNP-Cyt and TNP-Uri). If the trinitropheylation is 
successful, the selectively and impact of the CE-LIF method could be further expanded for the 
analysis of these molecules in biological samples. The synthesis of TNP-Gua, TNP-Cyt and 
TNP-Uri standards is the first step in expanding the CE-LIF method. Results from these 
experiments are discussed.
O
OH OH OH OH OH OH
Guanosine (Gua) Cytidine (Cyt) Uridine (Uri)
Figure B4.1. Structure of Guanosine (Gua), Cytidine (Cyt) and Uridine (Uri).
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B.3.2 Methods
A method similar to Green et al.1 and Hiratsuka et al.12 was followed for the 
trinitrophenylation of Gua, Cyt and Uri. ~60 mg of each compound was dissolved in 2 mL of 
Milli-Q H2O and 0.88 mL of TNBS (~1M in H2O) was added. The pH of all reactions was 
continuously monitored for 3 hours, adding 1 M NaOH until the pH was stabilized at 10. Each 
reaction was left overnight and purified the next morning on a Sephadex LH-20 column, 
dimensions 2 cm x ~30 cm. Impurities of each reaction were eluded off the column with water, 
leaving the purified standard, which appeared as a bright reddish-orange band, retained at the 
top of the column. The standards were then eluted from the column with methanol, dried by 
rotary evaporation and were analyzed for purity by 600 MHz NMR spectroscopy in D2O.
B.4.3 Results and Discussion
A pure standard of TNP-Gua was synthesized. Figure B4.2 shows the 1H NMR of TNP-Gua 
with correct hydrogen assignments. The large peak at ~4.8 ppm is D2O. A 1H NMR COSY was 
also acquired to further confirm the purity of TNP-Gua (Figure B4.3). It should be noted that 
during purification by column chromatography, the TNP-Gua standard took much longer to elute 
from the column (~2 days) compared to Ado and other molecules (~8 hr). During this time, the 
band corresponding to TNP-Gua also started to change color from a bright reddish-orange to a 
dark maroon-purple color.
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Figure B4.2. 1H NMR of TNP-Gua in D2O (Bruker 600 MHz).
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Figure B4.3 1H COSY NMR of TNP-Gua in D2O (Bruker 600 MHz).
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A pure standard of TNP-Cyt was synthesized. Figure B4.4 shows the 1H NMR of TNP-Cyt 
with correct hydrogen assignments. The large unassigned peak at ~4.8 ppm is D2O. A 1H NMR 
COSY was also acquired to further confirm the purity of TNP-Cyt (Figure B4.5).
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Figure B4.4. 1H NMR of TNP-Cyt in D2O (Bruker 600 MHz).
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Figure B4.5. 1H COSY NMR of TNP-Cyt in D2O (Bruker 600 MHz).
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A pure standard of TNP-Uri was also synthesized. Figure B4.6 shows the 1H NMR of TNP- 
Uri with correct hydrogen assignments. The large unassigned peak at ~4.8 ppm is D2O. A 1H 
NMR COSY was also acquired to further confirm the purity of TNP-Uri (Figure B4.7).
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Figure B4.6. 1H NMR of TNP-Uri in D2O (Bruker 600 MHz).
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Figure B4.7. 1H COSY NMR of TNP-Uri in D2O (Bruker 600 MHz). 
B.4.4 Conclusion
Pure standards of TNP-Gua, TNP-Cyt and TNP-Uri were successfully synthesized. Future 
experiments should be performed with these standards in addition to TNP-Ado, TNP-AMP, 
TNP-ADP and TNP-ATP to determine optimal CE-LIF conditions for successful analytical 
separation and quantification. Once these studies are complete, the trinitrophenylation reaction 
kinetics of each of these molecules at biologically relevant concentrations and volumes should 
be investigated to determine a standard reaction procedure for real biological samples. Lastly, 
once an optimized CE-LIF method and trinitrophenylation reaction procedure is established for 
TNP-Gua, TNP-Cyt and TNP-Uri, the expansion of the CE-LIF method for the detection of these 
molecules can be validated in real biological samples like brain tissue or microdialysis samples.
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